Portuguese Recommendations for the Diagnosis and Management of Gout
Objective: To develop Portuguese evidence-based recommendations for the Diagnosis and Management of Gout. Methods: As part of the 3e Initiative (Evidence, Expertise and Exchange), a panel of 78 international rheumatologists developed 10 relevant clinical questions which were investigated with systematic literature reviews. MEDLINE, EMBASE, Cochrane CENTRAL and abstracts from 2010-2011 EULAR and ACR meetings were searched. Based on the evidence found in the published literature, rheumatologists from 14 countries developed national recommendations that were merged and voted into multinational recommendations. We present the Portuguese recommendations for the Diagnosis and Management of Gout which were formulated and voted by Delphi method in April 2012, in Lisbon. The level of agreement and potential impact in clinical practice was also assessed. Results: Twelve national recommendations were elaborated from 10 international and 2 national questions. These recommendations addressed the diagnosis of gout; the treatment of acute flares and urate-lowering therapy; monitoring of gout and comorbidity screening; the influence of comorbidities in drug choice; lifestyle; flare prophylaxis; management of tophi and asymptomatic hyperuricaemia; the role of urine alkalinization; and the burden of gout. The level of agreement with the recommendations ranged from 6.8 to 9.0 (mean 7.7) on a 1-10 point visual analogue scale, in which 10 stands for full agreement. Conclusion: The 12 Portuguese recommendations for the Diagnosis and Management of Gout were formulated according to the best evidence and endorsed by a panel of 42 rheumatologists, enhancing their validity and practical use in daily clinical practice.
1. Department of Rheumatology, Hospital de Egas Moniz, Centro Hospitalar de Lisboa Ocidental EPE; 2. Institute of Microbiology, Faculdade de Medicina da Universidade de Lisboa
Inês Cordeiro
3. Department of Rheumatology, Hospital Garcia de Orta, Almada
Filipa Teixeira
4. Department of Rheumatology, Hospital Conde de Bertiandos, Ponte de Lima, Unidade Local de Saúde do Alto Minho EPE
João Rovisco
5. Department of Rheumatology, Centro Hospitalar e Universitário de Coimbra EPE
Sofia Ramiro
3. Department of Rheumatology, Hospital Garcia de Orta, Almada; 6. Clinical Immunology & Rheumatology, AMC, Amsterdam, The Netherlands
Ana Filipa Mourão
1. Department of Rheumatology, Hospital de Egas Moniz, Centro Hospitalar de Lisboa Ocidental EPE; 7. CEDOC, Faculdade de Ciências Médicas da Universidade Nova de Lisboa; 8. Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medici
José António Costa
4. Department of Rheumatology, Hospital Conde de Bertiandos, Ponte de Lima, Unidade Local de Saúde do Alto Minho EPE
José Bravo Pimentão
9. Rheumatology, Clínica Coração de Jesus, Lisboa
Armando Malcata
5. Department of Rheumatology, Centro Hospitalar e Universitário de Coimbra EPE
Maria José Santos
3. Department of Rheumatology, Hospital Garcia de Orta, Almada; 8. Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa
Jaime C. Branco
7. CEDOC, Faculdade de Ciências Médicas da Universidade Nova de Lisboa; 1. Department of Rheumatology, Hospital de Egas Moniz, Centro Hospitalar de Lisboa Ocidental EPE